
Behrens discussed strong data supporting secukinumab's use over ustekinumab post-TNF inhibitor in PsA.

Professor of Translational Rheumatology, Immunology, and Inflammation Medicine and Head of the Inflammation Clinic (Rheumatology, Inflammatory Skin Diseases, Inflammatory Bowel Diseases) at the Goethe-University Hospital and a Deputy Director of the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) at the Goethe-University Frankfurt

Behrens discussed strong data supporting secukinumab's use over ustekinumab post-TNF inhibitor in PsA.

Published: October 28th 2025 | Updated: